Inhibition of Multidrug Resistance-Associated Protein (MRP) Functional Activity with Pluronic Block Copolymers

AbstractPurpose. Using monolayers of human pancreatic adenocarcinoma cells (Panc-1) that express multidrug resistance-associated protein (MRP), the present work investigates the effects of Pluronic block copolymers on the functional activity of MRP. Methods. The studies examined the accumulation and efflux of the MRP selective probe fluorescein (FLU) in Panc-1 cell monolayers with and without Pluronic P85 (P85), Pluronic L81 (L81) and Pluronic F108 (F108). Results. Treatment of Panc-1 cells with P85 resulted in concentration-dependent increases in FLU accumulation and elimination of FLU sequestration in vesicular compartments in these cells. The effects of P85 were selective for FLU in the Panc-1 cell monolayers. Inhibition of MRP-mediated transport was dependent on the composition of Pluronic block copolymer: the more hydrophobic copolymer had the greater effect on FLU uptake in Panc-1 monolayers (L81 > P85 > F108). Conclusions. This paper demonstrates for the first time that Pluronic block copolymers inhibit multidrug resistance-associated protein (MRP). The similarities in the effects of Pluronic block copolymers on MRP and P-glycoprotein drug efflux systems suggest that a single unifying mechanism may explain the inhibition observed.

[1]  A. Krishan,et al.  Drug retention, efflux, and resistance in tumor cells. , 1997, Cytometry.

[2]  V. Alakhov,et al.  Hypersensitizing effect of pluronic L61 on cytotoxic activity, transport, and subcellular distribution of doxorubicin in multiple drug-resistant cells. , 1996, Cancer research.

[3]  A. Godwin,et al.  Expression pattern of MRP in human tissues and adult solid tumor cell lines. , 1995, Journal of the National Cancer Institute.

[4]  D. Keppler,et al.  Transport of glutathione, glucuronate, and sulfate conjugates by the MRP gene-encoded conjugate export pump. , 1996, Cancer research.

[5]  D. Miller,et al.  Expression of multidrug resistance-associated protein (MRP) in brain microvessel endothelial cells. , 1998, Biochemical and biophysical research communications.

[6]  G. Stoter,et al.  Molecular mechanisms of multidrug resistance in cancer chemotherapy. , 1996, Pathology, research and practice.

[7]  D. Miller,et al.  The expression of multidrug resistance-associated protein (MRP) in pancreatic adenocarcinoma cell lines. , 1996, Cancer letters.

[8]  Alexander V. Kabanov,et al.  Effects of Pluronic Block Copolymers on Drug Absorption in Caco-2 Cell Monolayers , 1998, Pharmaceutical Research.

[9]  A. Kabanov,et al.  Interactions of pluronic block copolymers with brain microvessel endothelial cells: evidence of two potential pathways for drug absorption. , 1997, Bioconjugate chemistry.

[10]  Twentyman Pr.  Transport proteins in drug resistance: biology and approaches to circumvention. , 1997 .

[11]  A. Kabanov,et al.  Hypersensitization of multidrug resistant human ovarian carcinoma cells by pluronic P85 block copolymer. , 1996, Bioconjugate chemistry.

[12]  Alexander V. Kabanov,et al.  Effects of Pluronic P85 Unimers and Micelles on Drug Permeability in Polarized BBMEC and Caco-2 Cells , 1998, Pharmaceutical Research.

[13]  S. Ward,et al.  A comparison of the phenomenology and genetics of multidrug resistance in cancer cells and quinoline resistance in Plasmodium falciparum. , 1998, Pharmacology & therapeutics.

[14]  D. Miller,et al.  Use of rhodamine 123 to examine the functional activity of P-glycoprotein in primary cultured brain microvessel endothelial cell monolayers. , 1996, Life sciences.

[15]  B. Sarkadi,et al.  Transport properties of the multidrug resistance‐associated protein (MRP) in human tumour cells , 1996, FEBS letters.

[16]  S. Levy,et al.  Indomethacin-mediated reversal of multidrug resistance and drug efflux in human and murine cell lines overexpressing MRP, but not P-glycoprotein. , 1997, British Journal of Cancer.

[17]  V. Alakhov,et al.  Block copolymeric biotransport carriers as versatile vehicles for drug delivery. , 1998, Expert opinion on biological therapy.

[18]  I. Pastan,et al.  P-glycoproteins: mediators of multidrug resistance. , 1993, Seminars in cell biology.

[19]  S. Cole,et al.  Structure and expression of the messenger RNA encoding the murine multidrug resistance protein, an ATP-binding cassette transporter. , 1996, Molecular pharmacology.

[20]  J. H. Beijnen,et al.  Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs , 1994, Cell.

[21]  D. Roden,et al.  The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors. , 1998, The Journal of clinical investigation.

[22]  M. Flens,et al.  Tissue distribution of the multidrug resistance protein. , 1996, The American journal of pathology.

[23]  A. Kabanov,et al.  Anthracycline antibiotics non-covalently incorporated into the block copolymer micelles: in vivo evaluation of anti-cancer activity. , 1996, British Journal of Cancer.

[24]  E. Moran,et al.  The multidrug-resistant human lung tumour cell line, DLKP-A10, expresses novel drug accumulation and sequestration systems. , 1997, Biochemical pharmacology.

[25]  Y. Abel,et al.  00 w P-glycoprotein-mediated acquired multidrug resistance of human lung cancer cells in vivo , 2007 .

[26]  W. Konings,et al.  Multidrug transporters from bacteria to man: similarities in structure and function. , 1997, Seminars in cancer biology.

[27]  S. Aaronson,et al.  Expression of multidrug resistance-associated protein in NIH/3T3 cells confers multidrug resistance associated with increased drug efflux and altered intracellular drug distribution. , 1995, Cancer research.